Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials

Home > Science Hub > Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials
Back to the list

April 7, 2025

Matt Clutter

You might also be interested by

Press Releases

CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development

July 15, 2026

More info

CellTalk Blog

B-Cell Monitoring in Autoimmune Programs: Expert Insights

June 30, 2026

More info

CellTalk Blog

CAR Kinetics in Autoimmune Studies: Expert Insights on Designing Effective Monitoring Strategies

June 30, 2026

More info

CellTalk Blog

Cytokine Profiling in Autoimmune Programs: Expert Insights on Assay Selection and Getting Data You Can Trust

June 30, 2026

More info